Medicated Shampoo Market (2026 - 2033)

Medicated Shampoo Market Summary

The global medicated shampoo market size was valued at USD 16.5 billion in 2025 and is projected to grow from USD 17.3 billion in 2026 to USD 23.8 billion in 2033, at a CAGR of 4.6% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 32.0% in 2025. The medicated shampoo market is driven by factors such as increased consumer awareness about scalp health, rising prevalence of scalp disorders, innovative product launches, and the influence of urbanization, e-commerce, and increasing disposable income on consumer purchasing habits.

Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

To learn more about this report, Download Free Sample Report

Growing consumer awareness of scalp health is a key driver of the medicated shampoos market. As individuals become increasingly conscious of maintaining scalp hygiene and managing conditions such as dandruff, psoriasis, and seborrheic dermatitis, the demand for therapeutic hair care products continues to rise. This shift in consumer preferences is encouraging the adoption of medicated shampoos that provide targeted treatment, symptom relief, and improved scalp health.

Product innovation is another key driver of the market, with continuous advancements in formulations and the introduction of natural and organic ingredients that enhance the effectiveness and appeal of medicated shampoos. The expansion of distribution channels, including online platforms, pharmacies, and specialty stores, has also improved consumer access and convenience, making it easier for people to purchase medicated shampoos. Effective marketing and endorsements by dermatologists have also built consumer trust and awareness, further driving market growth.

Demographic trends are also playing a significant role in driving the market, with an aging population and lifestyle changes contributing to increased health issues. The increasing prevalence of scalp disorders, including dandruff, psoriasis, and seborrheic dermatitis, has also created a need for effective treatment measures. Furthermore, the increase in customers' disposable income in the developing economy has enabled them to spend more on luxury hair care products, including medicated shampoos. The rise of online markets for product sales has also enabled easy access to various medicated shampoos, with convenient home delivery and better prices than retail stores being key factors fueling sales in this segment.

Analyst Perspective

The global medicated shampoo market is witnessing steady growth, driven by the rising prevalence of dandruff, seborrheic dermatitis, psoriasis, scalp fungal infections, and other dermatological conditions. Growing consumer awareness regarding scalp health, coupled with an increasing preference for treatment-oriented haircare products, is significantly boosting product adoption. The expanding availability of medicated shampoos through pharmacies, supermarkets, and e-commerce platforms has further improved product accessibility, supporting market growth across both developed and emerging economies. As consumers increasingly prioritize preventive scalp care and personalized treatment solutions, manufacturers focusing on scientifically validated formulations, premium product offerings, and omnichannel distribution strategies are well positioned to capitalize on the market's long-term growth opportunities.

Treatment Insights

Dandruff & seborrheic dermatitis treatment dominated the market, accounting for around 53.0% of revenue in 2025. Medicated shampoos contain active compounds such as zinc pyrithione, ketoconazole, and selenium sulfide, which have demonstrated clinical efficacy in treating dandruff and seborrheic dermatitis. Moreover, the growing demand for natural ingredients in personal care products has spurred the development of innovative shampoos that incorporate botanical extracts alongside conventional active ingredients, catering to consumers seeking natural alternatives with comparable efficacy.

Psoriasis treatment shampoos are expected to experience strong growth over the forecast period. Psoriasis is a chronic autoimmune condition characterized by rapid skin cell multiplication, leading to thick, red, and scaly skin. Despite its prevalence, the condition's severity varies among individuals. Medicated shampoos featuring coal tar, salicylic acid, and corticosteroids have been clinically proven to reduce inflammation, scaling, and itching associated with psoriasis. These ingredients have been shown to be effective in soothing scalp psoriasis symptoms, making them a preferred treatment option for consumers.

Distribution Channel Insights

Hypermarkets/supermarkets accounted for the largest revenue share of over 36.0% in 2025, as they offer a wide range of products, including medicated shampoos for various hair and scalp issues. Consumers can easily compare products on the same shelf. With established brands and trusted market presence, these outlets are often preferred by customers seeking reliable health products, including medicated shampoos.

Online distribution channels are expected to register the fastest growth over the forecast period. Online shopping offers consumers a convenient and accessible way to purchase medicated shampoos. From the comfort of their own homes, customers can browse a wide range of products, including those that may be embarrassing to purchase in-store. Online retailers often offer a broader selection and customer reviews, making it easier to make informed purchasing decisions.

Regional Insights

North America medicated shampoo market dominated the global medicated shampoo market with a revenue share of around 32.0% in 2025, driven by a high prevalence of scalp conditions such as dandruff, psoriasis, and seborrheic dermatitis among the population in the region. Strong distribution networks and competitive market presence also contribute to the region's dominance in the market.

To learn more about this report, Download Free Sample Report

The medicated shampoo market in the U.S. held a significant share in the North America medicated shampoo market in 2025. Rising consumer awareness about scalp health has driven growth in the country. Dermatologists and healthcare professionals emphasize the importance of proper scalp care, promoting medicated anti-dandruff shampoos over regular ones, which has led to increased demand for medicated shampoos.

Europe Medicated Shampoo Market Trends

Europe was the second-largest medicated shampoo market worldwide in 2025. Europe's regulatory framework for cosmetics and pharmaceutical products is notoriously stringent, with EMA and national health authorities enforcing rigorous standards for safety and efficacy. This rigorous approval process instills customer confidence, driving manufacturers to develop high-quality products that meet the region's exacting standards, ultimately contributing to a reputation for excellence in the medicated shampoo market.

The medicated shampoo market in Germany is poised for rapid growth, driven by the country's rich heritage in pharmacology and personal care production. The nation's well-developed R&D infrastructure and stringent regulatory framework have fostered innovation in dermatological treatments, positioning Germany as a hub for advancements in the medicated shampoo industry.

Asia Pacific Medicated Shampoo Market Trends

The Asia Pacific medicated shampoo market is expected to register the fastest growth during the forecast period. Rising middle-class consumerism in countries such as China and India, driven by economic growth, is fueling demand for personal care products, including medicated shampoos. As consumers increasingly prioritize quality and efficacy, the demand for premium products that meet specific needs is driving market growth and development, creating opportunities for businesses to capitalize on this trend.

The medicated shampoo market in China is poised for significant growth, driven by factors such as widespread education on personal hygiene, a high prevalence of skin-related issues, and a diverse range of products. The expansion of China's e-commerce sector has also enabled greater accessibility and convenience, further fueling market growth.

Key Medicated Shampoo Market Company Insights

Some key companies in the medicated shampoo market include Procter & Gamble, Himalaya Wellness Company, and Johnson & Johnson Services, Inc., among others. Competition in the market is expected to drive consolidation, with major players focusing on geographic expansion and growth of their customer base through product innovation, effective marketing, and strategic expansion.

• Procter & Gamble Co., a global consumer goods manufacturer, offers a diverse portfolio of products across beauty, grooming, healthcare, and other categories. The company's extensive range of medicated shampoos targets various scalp and hair issues, catering to the needs of a diverse customer base.
• Himalaya Wellness Company specializes in herbal care solutions for personal health and wellness. Its product portfolio includes dietary supplements, personal care products, and over-the-counter solutions. The company's medicated shampoo series addresses various hair and scalp concerns, providing effective solutions for customers.

Key Medicated Shampoo Companies

The following are the leading companies in the medicated shampoo market. These companies collectively hold the largest market share and dictate industry trends.

• Procter & Gamble

• Himalaya Wellness Company

• Johnson & Johnson Services, Inc.

• Unilever

• Henkel AG & Co. KGaA

• Kao Corporation

• Avalon Organics

• Summers Laboratories, Inc.

• Coty Inc.

Recent Developments

• In November 2024, Raven Innovations launched RestoraScalp, the world’s first medicated dry shampoo designed to support scalp health and relieve symptoms of dandruff and irritation. The product reflects growing innovation in convenient, treatment-based haircare formats within the medicated shampoo market.

• In November 2024, CeraVe expanded into the haircare segment with the launch of its first anti-dandruff shampoo and conditioner system, designed to eliminate visible flakes while maintaining scalp barrier health. The range targets mild to moderate dandruff and reflects growing demand for dermatologist-developed, scalp-care-focused medicated haircare products.

• In September 2024, ANI Pharmaceuticals announced the U.S. FDA approval and commercial launch of Ketoconazole Shampoo, 2%, the generic equivalent of Nizoral®. The prescription antifungal shampoo is indicated for the treatment of seborrheic dermatitis and other fungal scalp conditions. The launch strengthens ANI's dermatology portfolio while expanding access to the cost-effective therapeutic options, reflecting the growing demand for clinically proven medicated shampoos for managing scalp disorders.

Global Medicated Shampoo Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the medicated shampoo market report based on treatment, distribution channel, and region:

• Treatment Outlook (Revenue, USD Billion, 2021 - 2033)

  • Dandruff & Seborrheic Dermatitis

  • Psoriasis

  • Tinea Capitis

  • Head Lice

  • Allergic Reactions

• Distribution Channel Outlook (Revenue, USD Billion, 2021 - 2033)

  • Hypermarkets / Supermarkets

  • Convenience Stores

  • Online

  • Other Distribution Channels

• Regional Outlook (Revenue, USD Billion, 2021 - 2033)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

  • Asia Pacific

    • China

    • India

    • Japan

    • South Korea

    • Australia & New Zealand

  • Central & South America

    • Brazil

  • Middle East & Africa

    • South Africa